<産業資料/調査レポートの題名> 2022年7月15日

医薬品連続製造の世界市場:製品別(統合連続システム、半連続システム、制御&ソフトウェア)、用途別(最終医薬品製造、API製造)、エンドユーザー別(製薬会社、受託製造組織、その他)


◆英文タイトル:Pharmaceutical Continuous Manufacturing Market by Product (Integrated Continuous Systems, Semicontinuous Systems, and Control & Software), Application (Final Drug Product Manufacturing and API Manufacturing), and End User (Pharmaceutical Companies, Contract Manufacturing Organizations, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026

Chapter 1: Introduction

1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments

1.3.1. List of Key Players Profiled In The Report

1.4. Research Methodology

1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models

Chapter 2: Executive Summary

2.1. Key Findings of The Study
2.2. Cxo Perspective

Chapter 3: Market Overview

3.1. Market Definition And Scope
3.2. Key Findings

3.2.1. Top Investment Pockets
3.2.2. Market Player Positioning, 2018

3.3. Market Dynamics

3.3.1. Drivers

3.3.1.1. Increase In Government Support For Continuous Manufacturing Adoption
3.3.1.2. Advantages offered By Continuous Manufacturing Systems
3.3.1.3. Surge In Adoption of Pharmaceutical Continuous Manufacturing Systems

3.3.2. Restraint

3.3.2.1. Poor Demand In Under Developed Countries

3.3.3. Opportunities

3.3.3.1. Growth Opportunities In Emerging Markets

3.3.4. Impact Analysis

Chapter 4: Pharmaceutical Continuous Manufacturing Market, By Product

4.1. Overview

4.1.1. Market Size And Forecast

4.2. Integrated Continuous Systems

4.2.1. Key Market Trends And Opportunities
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Analysis, By Country

4.3. Semi-Continuous Systems

4.3.1. Key Market Trends And Opportunities
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Analysis, By Country

4.4. Control & Software

4.4.1. Key Market Trends And Opportunities
4.4.2. Market Size And Forecast, By Region
4.4.3. Market Analysis, By Country

Chapter 5: Pharmaceutical Continuous Manufacturing Market, By Application

5.1. Overview

5.1.1. Market Size And Forecast

5.2. Final Drug Product Manufacturing

5.2.1. Market Size And Forecast
5.2.2. Market Analysis, By Country

5.3. Api Manufacturing

5.3.1. Market Size And Forecast
5.3.2. Market Analysis, By Country

Chapter 6: Pharmaceutical Continuous Manufacturing Market, By End User

6.1. Overview

6.1.1. Market Size And Forecast

6.2. Pharmaceutical Companies

6.2.1. Market Size And Forecast
6.2.2. Market Analysis, By Country

6.3. Contract Manufacturing Organizations

6.3.1. Market Size And Forecast
6.3.2. Market Analysis, By Country

6.4. Others

6.4.1. Market Size And Forecast
6.4.2. Market Analysis, By Country

Chapter 7: Pharmaceutical Continuous Manufacturing Market, By Region

7.1. Overview

7.1.1. Market Size And Forecast

7.2. North America

7.2.1. Key Market Trends, Growth Factors, And Opportunities
7.2.2. Market Size And Forecast, By Country

7.2.2.1. U.S.

7.2.2.1.1. U.S. Pharmaceutical Continuous Manufacturing Market, By Product
7.2.2.1.2. U.S. Pharmaceutical Continuous Manufacturing Market, By Application
7.2.2.1.3. U.S. Pharmaceutical Continuous Manufacturing Market, By End User

7.2.2.2. Canada

7.2.2.2.1. Canada Pharmaceutical Continuous Manufacturing Market, By Product
7.2.2.2.2. Canada Pharmaceutical Continuous Manufacturing Market, By Application
7.2.2.2.3. Canada Pharmaceutical Continuous Manufacturing Market, By End User

7.2.2.3. Mexico

7.2.2.3.1. Mexico Pharmaceutical Continuous Manufacturing Market, By Product
7.2.2.3.2. Mexico Pharmaceutical Continuous Manufacturing Market, By Application
7.2.2.3.3. Mexico Pharmaceutical Continuous Manufacturing Market, By End User

7.2.3. North America Market Size And Forecast, By Product
7.2.4. North America Market Size And Forecast, By Application
7.2.5. North America Market Size And Forecast, By End User

7.3. Europe

7.3.1. Key Market Trends, Growth Factors, And Opportunities
7.3.2. Market Size And Forecast, By Country

7.3.2.1. Germany

7.3.2.1.1. Germany Pharmaceutical Continuous Manufacturing Market, By Product
7.3.2.1.2. Germany Pharmaceutical Continuous Manufacturing Market, By Application
7.3.2.1.3. Germany Pharmaceutical Continuous Manufacturing Market, By End User

7.3.2.2. France

7.3.2.2.1. France Pharmaceutical Continuous Manufacturing Market, By Product
7.3.2.2.2. France Pharmaceutical Continuous Manufacturing Market, By Application
7.3.2.2.3. France Pharmaceutical Continuous Manufacturing Market, By End User

7.3.2.3. Uk

7.3.2.3.1. Uk Pharmaceutical Continuous Manufacturing Market, By Product
7.3.2.3.2. Uk Pharmaceutical Continuous Manufacturing Market, By Application
7.3.2.3.3. Uk Pharmaceutical Continuous Manufacturing Market, By End User

7.3.2.4. Italy

7.3.2.4.1. Italy Pharmaceutical Continuous Manufacturing Market, By Product
7.3.2.4.2. Italy Pharmaceutical Continuous Manufacturing Market, By Application
7.3.2.4.3. Italy Pharmaceutical Continuous Manufacturing Market, By End User

7.3.2.5. Rest of Europe

7.3.2.5.1. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Product
7.3.2.5.2. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Application
7.3.2.5.3. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By End User

7.3.3. Europe Market Size And Forecast, By Product
7.3.4. Europe Market Size And Forecast, By Application
7.3.5. Europe Market Size And Forecast, By End User

7.4. Asia-Pacific

7.4.1. Key Market Trends, Growth Factors, And Opportunities
7.4.2. Market Size And Forecast, By Country

7.4.2.1. Japan

7.4.2.1.1. Japan Pharmaceutical Continuous Manufacturing Market, By Product
7.4.2.1.2. Japan Pharmaceutical Continuous Manufacturing Market, By Application
7.4.2.1.3. Japan Pharmaceutical Continuous Manufacturing Market, By End User

7.4.2.2. China

7.4.2.2.1. China Pharmaceutical Continuous Manufacturing Market, By Product
7.4.2.2.2. China Pharmaceutical Continuous Manufacturing Market, By Application
7.4.2.2.3. China Pharmaceutical Continuous Manufacturing Market, By End User

7.4.2.3. India

7.4.2.3.1. India Pharmaceutical Continuous Manufacturing Market, By Product
7.4.2.3.2. India Pharmaceutical Continuous Manufacturing Market, By Application
7.4.2.3.3. India Pharmaceutical Continuous Manufacturing Market, By End User

7.4.2.4. Rest of Asia-Pacific

7.4.2.4.1. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Product
7.4.2.4.2. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Application
7.4.2.4.3. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By End User

7.4.3. Asia-Pacific Market Size And Forecast, By Product
7.4.4. Asia-Pacific Market Size And Forecast, By Application
7.4.5. Asia-Pacific Market Size And Forecast, By End User

7.5. Lamea

7.5.1. Key Market Trends, Growth Factors, And Opportunities
7.5.2. Market Size And Forecast, By Country

7.5.2.1. Brazil

7.5.2.1.1. Brazil Pharmaceutical Continuous Manufacturing Market, By Product
7.5.2.1.2. Brazil Pharmaceutical Continuous Manufacturing Market, By Application
7.5.2.1.3. Brazil Pharmaceutical Continuous Manufacturing Market, By End User

7.5.2.2. South Africa

7.5.2.2.1. South Africa Pharmaceutical Continuous Manufacturing Market, By Product
7.5.2.2.2. South Africa Pharmaceutical Continuous Manufacturing Market, By Application
7.5.2.2.3. South Africa Pharmaceutical Continuous Manufacturing Market, By End User

7.5.2.3. Saudi Arabia

7.5.2.3.1. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Product
7.5.2.3.2. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Application
7.5.2.3.3. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By End User

7.5.2.4. Rest of Lamea

7.5.2.4.1. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By Product
7.5.2.4.2. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By Application
7.5.2.4.3. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By End User

7.5.3. Lamea Market Size And Forecast, By Product
7.5.4. Lamea Market Size And Forecast, By Application
7.5.5. Lamea Market Size And Forecast, By End User

Chapter 8: Company Profiles

8.1. Coperion Gmbh

8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Key Strategic Moves And Developments

8.2. Gea Group Ag

8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segments
8.2.4. Product Portfolio
8.2.5. Business Performance

8.3. Gebrüder Lödige Maschinenbau Gmbh

8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Operating Business Segments
8.3.4. Product Portfolio

8.4. Glatt Gmbh

8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segments
8.4.4. Product Portfolio

8.5. Hosokawa Micron Corporation

8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Product Portfolio
8.5.4. Business Performance

8.6. Korsch Ag

8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Operating Business Segments
8.6.4. Product Portfolio

8.7. L.B. Bohle Maschinen + Verfahren Gmbh

8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Operating Business Segments
8.7.4. Product Portfolio

8.8. Munson Machinery Company, Inc.

8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Operating Business Segments
8.8.4. Product Portfolio

8.9. Robert Bosch Packaging Technology Gmbh

8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Operating Business Segments
8.9.4. Product Portfolio
8.9.5. Business Performance

8.10. Thermo Fisher Scientific, Inc.

8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Product Portfolio
8.10.5. Business Performance


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark